Clinical Trial: A Prospective, Single-Arm, Phase II Clinical Trial of MRG003 Combined with Finotonlimab for Locally Advanced Squamous Cell Carcinoma of the Head and Neck (China)

Posted On: 2026-09-24

China, Sept. 24 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Prospective, Single-Arm, Phase II Clinical Trial of MRG003 Combined with Finotonlimab for Locally Advanced Squamous Cell Carcinoma of the Head and Neck'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600133273

Registration Time: 2026/09/23

Type: Interventional study

Primary Sponsor: The First People's Hospital of Foshan

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=329866

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: A Prospective, Single-Arm, Phase II Clinical Trial of MRG003 Combined with Finotonlimab for Locally Advanced Squamous Cell Carcinoma of the Head and Neck (China)